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Abstract 
Among the differential diagnoses that should be considered in acute respiratory failure (ARF) 
are infectious processes, autoimmune diseases, interstitial pulmonary fibrosis, and pulmonary 
neoplasia. Timely diagnosis of lung neoplasia is complicated in the early stages. An opportune 
diagnosis, as well as the specific treatment, decrease mortality. ARF occurs 1 in 500 pregnancies 
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and is most common during the postpartum period. Among the specific etiologies that cause 
ARF during pregnancy that must be considered are: (1) preeclampsia; (2) embolism of amniotic 
fluid; (3) peripartum cardiomyopathy; and (4) trophoblastic embolism. The case of a 36-year-
old patient with a 33-week pregnancy and ARF is presented. The patient presented dyspnea 
while exerting moderate effort that progressed to orthopnea and type 1 respiratory insuffi-
ciency. Imaging studies showed bilateral alveolar infiltrates and predominantly right areas of 
consolidation. Blood cultures, a galactomannan assay and IgG antibodies against mycoplasma 
pneumoniae, were reported as negative. Autoimmune etiology was ruled out through an im-
munoassay. A percutaneous pulmonary biopsy was performed and an invasive pulmonary ad-
enocarcinoma with lepidic growth pattern (i.e. lepidic pulmonary adenocarcinoma, LPA) result 
was reported. This etiology is rare and very difficult to recognize in acute respiratory failure 
cases. After infectious, autoimmune and interstitial lung fibrosis have been excluded the clini-
cian must suspect of lung cancer in a patient with acute respiratory failure and chest imaging 
compatible with the presence of ground-glass nodular opacities, a solitary nodule or mass with 
bronchogram, and lung consolidation. In the presence of acute respiratory failure, the suspi-
cion of pulmonary neoplasia in an adult of reproductive age must be timely. Failure to recog-
nize this etiology can lead to fatal results. © 2018 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
Acute respiratory failure (ARF) is a rare clinical entity during pregnancy, occurring in 1 
in 500 pregnancies [1]. In ARF, the inadequate gas exchange may be due to pulmonary and 
extrapulmonary conditions. ARF can produce type 1 (i.e. hypoxemic) or type 2 (i.e. hypercap-
nic) respiratory failure. Specific causes of ARF in pregnancy include etiologies such as: (1) ab-
rupt placenta; (2) embolism of amniotic fluid; (3) sepsis (e.g. chorioamnionitis); (4) 
preeclampsia (e.g., secondary pulmonary edema); and (5) trophoblastic pulmonary embolism 
[1]. Among the factors that may increase the risk of ARF are viral pneumonitis, non-obstetric 
sepsis, asthma, air embolism, thromboembolic disease, vascular disease, and pulmonary hy-
pertension [1]. Other non-specific medical conditions that are associated with ARI are trauma, 
pancreatitis, and neuromuscular disorders [1]. The clinical picture of an ARF varies according 
to the etiology. At the onset, ARF can commence as an increase in respiratory rate associated 
with accessory respiratory muscle use (i.e. scalene and sternocleidomastoid muscles) or as 
tachycardia and is often associated with signs related with to adrenergic release (e.g. diapho-
resis) [2]. Treatment for ARF should be directed toward attending the underlying disorder, 
ensuring proper airway management, assessing respiratory pattern, and adequate circulatory 
perfusion [2]. The medical relevance of this case report pertains to the opportune screening 
for lung cancer in cases of acute respiratory failure where infectious, autoimmune and inter-
stitial pulmonary fibrosis have been excluded. 
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A 36-year-old female with a 33-week pregnancy arrived at the Emergency Department 
complaining of a dry cough and shortness of breath during the last four days. A couple of hours 
before seeking medical help, the patient presented dyspnea when exerting moderate effort 
(i.e. ascending approximately eight steps) and heart palpitations that subsided with rest. The 
respiratory distress had a torpid evolution, as the dyspnea progressed to orthopnea before 
seeking medical attention. Additionally, the patient presented generalized malaise (i.e. myal-
gia and arthralgia). The patient’s family history included a mother with type 2 diabetes and 
arterial hypertension; other relevant aspects of family history were questioned and denied. 
Among the patient’s personal history, she reported tobacco consumption for more than 5 
years of approximately five cigarettes per day (i.e. 1.25 pack-year smoking history), suspend-
ing its consumption during the pregnancy. The patient denied use of controlled substances, 
allergies, past blood transfusions, traveling to regions with endemic diseases within the last 
three months, tattoos and body piercings. The patient had no history of lung disease, asthma 
during childhood, and chronic or degenerative diseases. The patient reported four pregnan-
cies, one delivery, and two cesarean surgeries, without any complications in regards to her 
past obstetric history. At the moment of her Emergency Department admission, the patient 
reported a 33-week pregnancy with normal evolution. 
Upon initial physical exploration, we found a recumbent patient with freely chosen body 
position, Glasgow coma score of 15, without focal neurologic deficits nor meningeal sings, 
aware of his environment, with reference to place, time, and people. The patient was diapho-
retic, with skin and mucosae dehydrated +/+++. The head and neck exploration had no alter-
ations. Upon inspection, the respiratory apparatus with oral ventilation, along with tachypnea 
associated with thoracic and abdominal dissociation. The thorax had decreased expansion 
without vibrations or fremitus during palpation. No asymmetries or abnormal findings in tone 
intensity, pitch, duration, and quality through direct percussion. Upon auscultation, dissemi-
nated bilateral crepitant crackles and bilateral decreased inspiratory breath sounds were 
found at the bases. Precordial auscultation revealed tachycardia and heart sounds of good in-
tensity without extra heart sounds. The abdominal exploration presented a globous abdomen 
secondary to a gestating uterus with a live single product (i.e. a fetal heart rate of 158 bpm), 
without visceromegaly nor abnormalities upon light and deep palpation. The extremities had 
a filiform pulse augmented in frequency and decreased in amplitude without trophic changes. 
Upon admission, the patient had the following vital signs: BP of 130/90 mm Hg; HR of 100 
bpm; RR of 21 rpm; SO2 with noninvasive ventilation at a rate of 10 L/min of 74%; tempera-
ture of 36°C; body-weight of 70 kg; height of 165 cm; and BMI of 25.7. 
The patient developed type one respiratory insufficiency (i.e. vital signs: BP: 130/85 mm 
Hg, HR: 120 bpm, RR: 36 rpm, Temp: 36.7°C; arterial blood gas test: pH = 7.4, PaO2 = 43 mm 
Hg, PaCO2 = 24 mm Hg, HCO3– = 16.9 mEq/L, O2 content = 78%, base excess = –7.0 mmol/L, 
lactate = 0.9 mmol/L), while being under observation at the Emergency Department; conse-
quently, requiring invasive artificial airway with an endotracheal tube. The patient presented 
thoracic and abdominal dissociation, intercostal retractions and diaphoresis. The patient was 
surgically intervened in a cesarean emergency procedure. A live newborn male of 1940gr was 
obtained, without malformations; additionally, a 400 cc hemorrhage was reported during the 
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surgical procedure. The patient was admitted to the Intensive Care Unit for further tests and 
treatment. 
Laboratory results at admission are presented in Table 1. On a chest x-ray, the posterior-
anterior projection shows bilateral opacities with predominance in the lower lobes (Fig. 1A). 
Bilateral alveolar infiltrates and areas of consolidation with a right predominance at the bases 
were evident in a computed tomography (CT) of the thorax (Fig. 2A–2D). Due to the clinical 
picture and imaging findings, an infectious process was suspected and was further explored. 
Antimicrobial treatment was initiated with one gram of intravenous (IV) ceftriaxone every 12 
h and clarithromycin 500 mg orally (PO) every 12 h for 7 days. 
Clinical Evolution 
Upon the patient’s admission to the Intensive Care Unit, consecutive blood cultures of 
each extremity, a culture of bronchial secretions, IgG antibodies against Mycoplasma pneu-
monie and a galactomannan assay to exclude aspergillosis were performed; all being reported 
negative. Serum procalcitonin levels of 0.02 ng/mL were reported. The urinalysis reported 
abundant bacteria, erythrocytes 118 per field, as well as leukocytes of 163 per high power 
field (Table 2). In search of an autoimmune etiology, immunoassays were requested and re-
ported as negative (Table 2). 
Forty-eight hours after admission to the Intensive Care Unit the patient was extubated, 
presenting adequate respiratory mechanics. Due to the patient’s clinical improvement and in 
absence of respiratory failure (i.e. arterial blood gas test: pH = 7.46, PaO2 = 74.9 mm Hg, PaCO2 
= 39 mm Hg, HCO3– = 28 mEq/L, O2 content = 95.6%, base excess = 6.0 mmol/L, lactate = 0.5 
mmol/L), but still dependent on supplemental oxygen, the patient was admitted to the Inter-
nal Medicine Department. An echocardiogram was performed reporting a left ventricular ejec-
tion fraction of 66% and normal systolic function; however, mild diastolic dysfunction, yet 
excluding a decompensated heart failure as a cause of the ARF. A global pericardial effusion 
with a posterior predominance of approximately 300 cubic centimeters was detected, without 
evidence of intracavitary thrombi, nor evidence of valvular pathology (Fig. 1C, D). 
A CT-guided percutaneous lung biopsy was performed during the second week of hospi-
talization (Fig. 3A, B). The histopathological report reported moderately differentiated malig-
nant neoplasia compatible with invasive pulmonary adenocarcinoma with lepidic growth pat-
tern (Fig. 3C. D). Immunohistochemistry studies were performed (Table 2) integrating a pul-
monary neoplasia diagnosis. As a complication of the invasive procedure, the patient pre-
sented a pneumothorax greater than 25% in the right hemithorax (Fig. 1B). A tube thora-
costomy was performed, placing an endopleural tube on the on the right mid-axillary line to 
correct for the presence of pleural effusion. Pleural effusion was examined and the report de-
scribed the presence of liquid compatible to exudate according to the Light criteria for pleural 
effusions. 
The patient was evaluated by the Oncology Department, classifying the patient as com-
pletely disabled (i.e. ECOG 4) and making the determination that chemotherapy administra-
tion was contraindicated due to an unresolved sepsis process. Sepsis of unknown origin was 
integrated as follow-up urinalyses, urine culture and blood cultures were negative and no pul-
monary septic process could be confirmed. Additionally, after her condition and prognosis 
 Case Rep Oncol 2018;11:822–834 
DOI: 10.1159/000495460 © 2018 The Author(s). Published by S. Karger AG, Basel 
www.karger.com/cro 
Jiménez-Zarazúa et al.: Invasive Pulmonary Adenocarcinoma with Lepidic Growth Pattern 






were explained to the patient, she did not accept any further medical assistance or interven-
tions. After assessment by the Oncology Department, a palliative care protocol was initiated 
with the administration of morphine for dyspnea and pain control. The following two weeks 
the patient had a torpid clinical evolution (i.e. continued orthopnea, a temperature of 39°C, 
and leukocytosis; Table 2). After a total of 30 days of hospitalization, the patient presented 
extreme bradycardia, progressing to asystole and death. The family of the patient did not wish 
for a necropsy to be performed. 
Discussion 
Performing the diagnosis of a neoplasm during pregnancy is a challenge for the clinician. 
Physiological adaptations associated with pregnancy may mask the symptoms suggestive of 
cancer [3]. This case report presents a pregnant patient with acute respiratory failure second-
ary to an invasive pulmonary adenocarcinoma with lepidic growth pattern. In this case report, 
through clinical exploration, laboratory and imaging studies, an infectious process, an auto-
immune disease, and an interstitial lung fibrosis were excluded; therefore, after a CT-guided 
percutaneous lung biopsy, an invasive pulmonary adenocarcinoma with lepidic growth pat-
tern diagnosis was confirmed through histopathological examination. The main objective of 
this case report is to contribute to the existing medical literature a case of ARF with an etiology 
difficult to diagnose, which is the case of pulmonary neoplasia in a pregnant patient. 
Neoplasms associated with pregnancy are reported to occur in 1 out of every 1,000 preg-
nancies and more recently an incidence of 122.9 cancer cases for every 100,000 pregnancies 
[4]. Breast cancer, thyroid cancer, and lymphomas are cancers most commonly associated 
with pregnant women [5]. Lung cancer is divided into two types: (1) non-small cell lung cancer 
(NSCLC), which represents approximately 85% of all lung cancers; and (2) small cell lung can-
cer, which represents the remaining 15% [6]. Although progress regarding early detection of 
non-small cell lung cancer has been made, it is usually diagnosed at an advanced stage; thus, 
resulting in poor prognosis [6]. Weight loss, coughing, dyspnea, weakness, and chest pain are 
among the clinical manifestations of lung cancer [7]. The most frequent NSCLC is invasive lung 
adenocarcinoma, with five subtypes: (1) lepidic; (2) acinar; (3) solid; (4) papillary; and (5) 
micropapillary [8]. LPA is the most common form of adenocarcinoma proliferation, possessing 
a unique histological pattern termed lepidic growth. Lepidic growth is characterized by type 
II pneumocyte proliferation along the alveolar structure [9]. LPA affects primarily women, 
with the most frequent symptoms being: (1) weight loss (35.9–46%); (2) coughing (45–
54.7%); (3) dyspnea (37–45.3%); (4) weakness (34%); (5) chest pain (27%) and (6) hemop-
tysis (17.4–27%) [7]. According to a tumor resection study, most lung cancers present clinical 
symptoms in an advanced stage and surgical interventions are considered the ‘gold’ standard 
for the treatment of early NSCLC and some late NSCLC cases [9]. 
The patient presented in this case report only presented dyspnea, which progressed to 
orthopnea within a matter of days; developing type 1 respiratory insufficiency while being 
observed in the Emergency Department. Due to the acute onset of the respiratory failure, ne-
oplasia was not the first etiology considered in this case’s diagnostic algorithm. After assess-
ment by the Obstetrics Department and given that the patient was intubated in order to pro-
vide adequate ventilation, the interruption of the pregnancy was decided by performing a 
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cesarean-type surgical intervention. The offspring’s well-being was immediately procured by 
ending the pregnancy and no fetal suffering being reported. Adequate fetal oxygenation re-
quires a PaO2 approximately of 70 mm Hg, which corresponds to a saturation of maternal O2 
of around 95% [10]. The effect of maternal hypercapnia on the fetus is not well defined. Lim-
ited research data on neonates reports that a PaCO2 of 44–55 mm Hg can be well tolerated by 
the newborns [10]. 
Due to the gradual progression of the clinical picture, an infectious process was initially 
considered to be the cause of the patient’s ARF. Our first diagnostic inquiry was substantiated 
on the clinical (i.e. orthopnea, myalgia, and arthralgia) and radiological findings (i.e. alveolar 
infiltrates and pulmonary consolidation) compatible with a pneumonic process. To exclude an 
infectious process, blood cultures of each extremity, a culture of bronchial secretions, IgG an-
tibodies against Mycoplasma pneumonie and a galactomannan assay to exclude aspergillosis 
were performed and were reported negative. To investigate the cause of the pericardial effu-
sion of approximately 300 cc a transthoracic echocardiogram was performed to exclude a 
heart failure diagnosis. Only a mild diastolic failure was reported, which did not justify the 
patient’s clinical picture. 
A chest radiograph is often the first imaging modality to suggest the diagnosis of lung ne-
oplasia and recent lung cancer screening guidelines recommend low-dose CT screening in cer-
tain cases [11]. However, none of the recent evidence-based recommendations for CT screen-
ing applied to the case presented; furthermore, highlighting the complexity of this case. Lung 
adenocarcinoma has three radiological patterns, as a solitary nodule (i.e. 60–90%), as a dense 
consolidation (i.e. up to 20%), and as multiple small sub-centimeter irregularly marginal nod-
ules (i.e. rare) [12]. LPA is associated with a solitary nodule, which also is characterized by a 
ground-glass opacification pattern, mainly observed at the periphery of the lesion [12]. The 
case presented here had a dense condensation pattern resembling a pneumonic process and 
was also associated with a ground-glass opacification pattern. The pathological stage is the 
most important prognostic factor in patients with this pulmonary adenocarcinoma. The over-
all five year survival by pathological stage is 90, 85, 80, 73, 65, 56, 41, 24, and 12% for the IA1, 
IA2, IA3, IB, IIA, IIB, IIIA, IIIB, and IIIC according to the average overall survival in the Interna-
tional Association for the Study of Lung Cancer global database of patients receiving a diagno-
sis between 1999 and 2010. The case presented in this article is classified as a stage IIIA given 
its bilateral pulmonary disease through CT imaging and tissue biopsy [13]. 
Limitations and Further Considerations 
One of the great limitations for an opportune diagnosis of pulmonary adenocarcinoma is 
the diagnostic accuracy of CT for this pathology. Aherne and colleagues (2018), report a series 
of cases that included 63 patients with pulmonary neoplasia with a lepidic component, where 
the radiological findings by CT were correlated with histopathological findings [14]. The au-
thors reported an association between the size of the CT lesion and the histopathological di-
agnosis; specifically, a sensitivity of 0.719 (95% CI: 0.533–0.863) and a specificity of 0.704 
(95% CI: 0.498–0.862), when using the cut-off value for a lesion of 7.5 mm [14]. 
Pneumonia is among the first differential diagnosis for a radiological lung consolidation 
syndrome by CT. This was the initial diagnostic suspicion in the clinical case presented. Lym-
phoproliferative disorders (e.g. primary lymphoma of mucosa-associated lymphoid tissue) 
should also be excluded. These disorders usually present as a single nodule or consolidation 
 Case Rep Oncol 2018;11:822–834 
DOI: 10.1159/000495460 © 2018 The Author(s). Published by S. Karger AG, Basel 
www.karger.com/cro 
Jiménez-Zarazúa et al.: Invasive Pulmonary Adenocarcinoma with Lepidic Growth Pattern 






opacity only in 33% of cases or as multiple nodules or consolidation of multiple areas in 43% 
of the cases [15]. Secondary lymphoma also has a similar presentation by CT; however, it is 
characterized by the presence of nodules and tumors with or without air bronchogram [15]. 
Among the lesions that may present ground-glass opacities are: focal interstitial fibrosis; as-
pergillosis; eosinophilic pneumonia; bronchiolitis obliterans with organizing pneumonia; tho-
racic endometriosis; focal traumatic lung injury; pulmonary Cryptococcus; inflammatory dis-
eases, and focal hemorrhage. In this patient, serological detection of different antibodies was 
performed to exclude an immunological process before suspecting in a neoplasm. 
Although lung tissue biopsy is an invasive diagnostic technique, it is a justified diagnostic 
measure in ARF cases where an infectious and autoimmune diagnosis has been excluded. Lung 
tissue biopsy can assist in the differential diagnosis between a neoplastic process and an in-
terstitial pulmonary disease. Due to lack of access to bronchoscopy, a CT-guided biopsy was 
performed. A percutaneous image-guided biopsy is a safe and effective method to obtain a 
diagnosis of focal lesions. A percutaneous image-guided biopsy is a preferred technique for 
the diagnosis of new or growing lung nodules or when a bronchoscopy reports negative re-
sults for a persistent opacity of the airspace or hilar tumor. 
Conclusion 
In the presence of acute respiratory failure, the suspicion of pulmonary neoplasia in an 
adult of reproductive age must be timely. Lung cancer should be suspected in a patient with 
ARF and CT imaging compatible with the presence of ground-glass nodular opacities, a soli-
tary nodule or mass with bronchogram, and lung consolidation. As part of the diagnostic algo-
rithm of a patient of reproductive age, an infectious etiology, autoimmune etiologies (e.g. vas-
culitis and collagen disease), neoplastic processes (e.g. primary lymphoma, primary lym-
phoma of mucosa-associated lymphoid tissue and LPA), and interstitial pulmonary fibrosis 
should be excluded. The torpid evolution, in this case, is attributed to the concomitant sepsis 
process that the patient presented, which did not allow for treatment targeted for the lung 
cancer. The patient presented in this case had a locally advanced stage lung cancer corre-
sponding to IIIA according to The Eighth Edition Lung Cancer Stage Classification; further-
more, at this stage, tumor resection is recommended. Among the therapeutic options for IIIA 
stage lung cancer are radiotherapy and chemotherapy session followed by adjuvant therapy 
with a secondary anti-neoplastic agent or if the epidermal growth factor receptor mutation is 
present Gefitinib, Erlotinib, Afatinib, Osimertinib, and Necitumumab can be used [16]. 
Availability of Data and Materials 
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Fig. 1. Chest X-ray. Posterior-anterior projection. A) Bilateral opacities with predominance at the bases at 
admission. B) Bilateral alveolar infiltrates at the bases and areas of consolidation, with right predominance 
and bilateral progressive diffusion, compatible with ground-glass opacification images. The endopleural 
tube on the right side. Echocardiogram. Two-dimensional apical projection. C) Four chamber image show-
ing a normal interventricular septum, without intracavitary thrombi or evidence of valvular pathology. D) 
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Fig. 2. Computerized tomography (CT) of the thorax. Thoracic CT scan without contrast. A) Bilateral alve-
olar infiltrates with consolidation area (marked by *) in the right lung region. B) Bilateral alveolar infil-
trates and increased pericardic space due to pericardic effusion (marked by *). C) Consolidation area in 
right hemithorax area (marked by *). D) Consolidation area observed at the right superior lobule with 
multiple images compatible with ground-glass opacities and air bronchogram. 
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Fig. 3. Lung biopsy guided by CT. A) Biopsy needle at the fifth intercostal space in the dorsal aspect of the 
thorax. B) Biopsy needle at a mediastinal window. Histopathology. Lung. C) 10×, hematoxylin and eosin 
staining. Malignant neoplasm at the alveolar wall, partially respecting the alveolar lumen emitting projec-
tions resembling butterfly wings. D) 40×, hematoxylin and eosin staining. Alveolar wall coated with neo-
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Table 1. Laboratory test results upon admission to the Emergency Department 
  
  
Full blood count  
Hemoglobin at admission 0014.3 g/dL 
Hematocrit 0043.1% 
Erythrocyte count 005.43×106 µL 
Platelet count .00403 µL 
Mean corpuscular volume 0079.4 fL 
Mean corpuscular hemoglobin concentration 0026.2 g/dL 






Blood chemistry  
Glucose 0075.9 mg/dL 
Creatinine 0000.7 mg/dL 
Urea nitrogen 000.19 mg/dL 
Blood urea nitrogen 0008.8 mg/dL 
Uric acid 0005.4 mg/dL 
Cholesterol 00.150 mg/dL 
Triglycerides 00.170 mg/dL 
Liver Function Enzymes  
Aspartate transaminase 0033.1 U/L 
Alanine transaminase 0020.1 U/L 
Lactate dehydrogenase 0295.7 U/L 
Albumin 0003.1 g/dL 
Alkaline phosphatase 0163.8 U/L 
Gamma-glutamyl transpeptidase 000.20 
Blood coagulation  
Prothrombine time 0014.7 Sec 
Partial thromboplastin time 0036.4 Sec 
International normalized ratio 0001.1 
Electrolytes  
Sodium 0137.8 mEq/L 
Potassium 004.49 mEq/L 
Chlorine 0106.5 mEq/L 
Calcium 0008.3 mg/dL 
Phosphorus 004.45 mg/dL 
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Full Blood Count at 4 weeks  
Platelet count 339,000/µL 






Procalcinotin 10 ng/mL 
Antibodies  
Cytoplasmic antineutrophil cytoplasmatic antibodies (cANCA) 0.1 
Perinuclear antineutrophil cytoplasmatic antibodies (pANCA) 0.2 
Anti-double-stranded deoxyribonucleic acid 0.9 U/mL 
Anti. SSB-LA Negative 
Anti –SSA-RO Negative 
Anti-SM Negative 
Anti-cardiolipin IgG 2 U/mL 
Anti-cardiolipin IgM antibody 7.7 U/mL 
Cyclic citrullinated peptide antibody 1.5 U/mL 
Complement C3 1.5 gr/L 
Complement C4 0.5 gr/L 
Viral panel  
Hepatitis B virus Negative 
Hepatitis C virus Negative 
Human immunodeficiency virus Negative 
Urinalysis at 72 h  
Appearance Crystalline 
pH 6 
Specific gravity 1.020 
Proteins Negative 
Ketones, glucose, and nitrites Negative 
Leukocytes 163 per high power field 
Erythrocytes 118 per high power field 
Bacteria Abundant 
  
  
 
 
 
